Why Attend

Preliminary Agenda

Location & CLE

Wednesday, April 15

Reed Smith LLP | 1301 K St NW | Washington, DC 20005

8:45 – 9:15 AM
Registration and Continental Breakfast

9:15 – 9:20 AM
Welcome and Opening Remarks 
Laura Brown, Director, Educational Programs, Food and Drug Law Institute

9:20 – 10:00 AM
Keynote Address – Title I (Compounding Quality Act) Implementation – Pharmacy Compounding in 2020
Frances (Gail) Bormel, Associate Director for Compounding, CDER, FDA 

10:00 – 10:15 AM
Networking & Coffee Break 

12:00 – 1:00 PM
Networking Luncheon

2:00 – 2:15 PM
Networking Break & Coffee Break

2:15–3:45 PM
What to Watch in 2020: Recent and Upcoming FDA Guidance and Actions

4:45 PM
Conference Adjournment